Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CLELAND

Showing results (611-620 of 663) with videos related to

Pageof 67
Sort By:
European Journal of Heart Failure|February 24, 2022
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trialJoão Pedro Ferreira, Job A J Verdonschot, Nicolas Girerd, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 18, 2015
A combined clinical and biomarker approach to predict diuretic response in acute heart failureJozine M ter Maaten, Mattia A E Valente, Marco Metra, et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|March 23, 2026
Health status and effects of spironolactone in people at high risk of heart failure: the Heart OMics in AGEinging (HOMAGE) randomized trialInês Aguiar-Neves, Sílvia O Diaz, João Pedro Ferreira, et al.
Heart (British Cardiac Society)|August 12, 2017
Coronary angiography in worsening heart failure: determinants, findings and prognostic implicationsJoão Pedro Ferreira, Patrick Rossignol, Biniyam Demissei, et al.
European Journal of Heart Failure|October 30, 2018
Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHFToru Suzuki, Yoshiyuki Yazaki, Adriaan A Voors, et al.
Journal of the American College of Cardiology|February 2, 2018
Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHFWouter Ouwerkerk, Aeilko H Zwinderman, Leong L Ng, et al.
International Journal of Cardiology|November 29, 2018
Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fractionKoen W Streng, Jan F Nauta, Hans L Hillege, et al.
European Journal of Heart Failure|June 23, 2017
A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failureAbhinav Sharma, Biniyam G Demissei, Jasper Tromp, et al.
Circulation. Heart Failure|June 9, 2016
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart FailureJozine M Ter Maaten, Mattia A E Valente, Kevin Damman, et al.
Heart (British Cardiac Society)|February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trialShirley Sze, Iain Squire, Paul R Kalra, et al.
Pageof 67

Showing results (611-620 of 663) with videos related to

Sort By:
Pageof 67
European Journal of Heart Failure|February 24, 2022
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trialJoão Pedro Ferreira, Job A J Verdonschot, Nicolas Girerd, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 18, 2015
A combined clinical and biomarker approach to predict diuretic response in acute heart failureJozine M ter Maaten, Mattia A E Valente, Marco Metra, et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|March 23, 2026
Health status and effects of spironolactone in people at high risk of heart failure: the Heart OMics in AGEinging (HOMAGE) randomized trialInês Aguiar-Neves, Sílvia O Diaz, João Pedro Ferreira, et al.
Heart (British Cardiac Society)|August 12, 2017
Coronary angiography in worsening heart failure: determinants, findings and prognostic implicationsJoão Pedro Ferreira, Patrick Rossignol, Biniyam Demissei, et al.
European Journal of Heart Failure|October 30, 2018
Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHFToru Suzuki, Yoshiyuki Yazaki, Adriaan A Voors, et al.
Journal of the American College of Cardiology|February 2, 2018
Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHFWouter Ouwerkerk, Aeilko H Zwinderman, Leong L Ng, et al.
International Journal of Cardiology|November 29, 2018
Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fractionKoen W Streng, Jan F Nauta, Hans L Hillege, et al.
European Journal of Heart Failure|June 23, 2017
A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failureAbhinav Sharma, Biniyam G Demissei, Jasper Tromp, et al.
Circulation. Heart Failure|June 9, 2016
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart FailureJozine M Ter Maaten, Mattia A E Valente, Kevin Damman, et al.
Heart (British Cardiac Society)|February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trialShirley Sze, Iain Squire, Paul R Kalra, et al.
Pageof 67